Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FB9UM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,009
Award facts
- Contract value 100% obligated
- $36,009.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,009.02 to AmerisourceBergen Drug Corp for KESIMPTA 20 MG/0.4 ML Pen (0.4ML) on February 4, 2026, with an ultimate completion date of February 5, 2026. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This prime IDC vehicle enables comprehensive global pharmaceutical support, covering an extensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports military treatment facilities, veteran healthcare programs, and other federal medical institutions worldwide, with KESIMPTA being a specialty pharmaceutical product supplied to meet federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FB9UM?
SPE2DR26FB9UM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FB9UM worth?
The government has obligated $36,009 on SPE2DR26FB9UM.
Is contract SPE2DR26FB9UM an order under another contract?
Yes. SPE2DR26FB9UM is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9UM competed?
The extent of competition for SPE2DR26FB9UM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award